MD862G2 - Средство для лечения и профилактики дислипидемии и атеросклероза - Google Patents

Средство для лечения и профилактики дислипидемии и атеросклероза

Info

Publication number
MD862G2
MD862G2 MD97-0168A MD970168A MD862G2 MD 862 G2 MD862 G2 MD 862G2 MD 970168 A MD970168 A MD 970168A MD 862 G2 MD862 G2 MD 862G2
Authority
MD
Moldova
Prior art keywords
dislipidemy
remedy
atherosclerosis treatment
pectine
increasing
Prior art date
Application number
MD97-0168A
Other languages
English (en)
Romanian (ro)
Other versions
MD862F1 (en
Inventor
Виктория ИВАНОВ
Надежда КРАСНОВА
Original Assignee
Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова filed Critical Институтул Де Кардиолоджие Ал Министерулуй Сэнэтэций Дин Република Молдова
Priority to MD97-0168A priority Critical patent/MD862G2/ru
Publication of MD862F1 publication Critical patent/MD862F1/xx
Publication of MD862G2 publication Critical patent/MD862G2/ru

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Изобретение относится к медицине, а именно к кардиологии.Сущность изобретения состоит в том, что средствo для лечения и профилактики дислипидемии и атеросклероза на основе полисахаридов включает пектин с уровнем этерификации выше 70%, с гипохолестеролемическим эффектом, который содержит катионы кальция в количестве 300-500 мг-экв./кг, в частности яблочный пектин.Техническим результатом изобретения является увеличение гипохолестеролемических свойств с уменьшением триглициридов и повышением уровня C-HDL.
MD97-0168A 1997-06-23 1997-06-23 Средство для лечения и профилактики дислипидемии и атеросклероза MD862G2 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MD97-0168A MD862G2 (ru) 1997-06-23 1997-06-23 Средство для лечения и профилактики дислипидемии и атеросклероза

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MD97-0168A MD862G2 (ru) 1997-06-23 1997-06-23 Средство для лечения и профилактики дислипидемии и атеросклероза

Publications (2)

Publication Number Publication Date
MD862F1 MD862F1 (en) 1997-10-31
MD862G2 true MD862G2 (ru) 1998-07-31

Family

ID=19739022

Family Applications (1)

Application Number Title Priority Date Filing Date
MD97-0168A MD862G2 (ru) 1997-06-23 1997-06-23 Средство для лечения и профилактики дислипидемии и атеросклероза

Country Status (1)

Country Link
MD (1) MD862G2 (ru)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A.S. Truswell. " Dietary Fibre and Plasma Lipids: Potential for Prevention and Treatment of Hyperlipidaemias.Dietary Fibre-A component of food.1993.p.295-348. *
Cs. gastroenterologie, V.37,N1, E. Ginter, R. Kohn, A. Malovicova et al. " Zavislost. Hipolipemickeno ucinki pectinov na ich chemickom Zlozeni", p.37-46. *

Also Published As

Publication number Publication date
MD862F1 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
AP9901674A0 (en) Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders.
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
BG102726A (en) Combined therapy for osteoporosis
BG105556A (en) New esters derived from substituted phenyl-cyclohexyl compounds
GR970300016T1 (en) Lactobacillus strains of human origin, their compositions and uses thereof
IL214607A0 (en) 2,4-pyrimidinedinediamine compounds and their use in the manufacture of medicaments for the treatment of autoimmune disases
BG104943A (en) Biodegradable sustained-release alginate gels
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
ES2191174T3 (es) (-)hidroxicitrato de magnesio, procedimiento de preparacion, aplicaciones y composiciones principalmente farmaceuticas que lo contienen.
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
AU3259099A (en) Pharmaceutical composition based on natural synthesis progesterone and oestradiol and preparation method
MXPA04002565A (es) Combinacion de un inhibidor de il-1/18 con un inhibidor de tnf para el tratamiento de inflamacion.
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
EP0606903A3 (en) Interconnects.
ZA948B (en) Endothelin converting enzyme inhibitors
SI0951909T1 (en) Combination composition comprising a L-carnitine or an alkanoyl-L-carnitine, a glycosaminoglycan and/or constituent thereof
EP0940316A3 (en) Drawer tower
BG105256A (en) Muscarinic agonists and antagonists
AU4830097A (en) Use of an extract of Cimicifuga
EP0615728A3 (en) Orthopedic reconstruction plate.
EP1275379A3 (en) Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one
BR9812368A (pt) 2-aminotetralinas, processo para sua preparação, e composições farmacêuticas, para a prevenção e tratamento terapêutico de patologias inflamatórias e/ou autoimunes
AU6849198A (en) Neurotrypsin
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
NZ525536A (en) Treatment of arthritis and other similar conditions

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20170623

KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees